The first vector-delivered gene therapies to receive FDA approval for clinical use were Luxturna,1 Spark Therapeutics’ vision loss cure, and Zolgensma,2 Novartis’ spinal muscular atrophy treatment.
Viruses have evolved to invade host cells and hijack their cellular machinery to direct the replication and transcription of their own genomes. While these properties make viruses dangerous pathogens, ...
As Gartner Predicts Vector Databases Will Be Used in 30% of Enterprise Applications by 2026, Milvus Reaches Major Milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback